BR Holdings, a Korean distributor of Mazor Robotics, has received the Korean Food and Drug Administration (KFDA) approval to commercialize Mazor's Renaissance system.

Renaissance system is a surgical guidance system that utilizes robotic surgery technology to perform spine procedures.

Mazor CEO Ori Hadomi said Korean spine surgeons performed 120,000 cases in 2008, reflecting 18% annual growth from 2003.

"As an example, the Korean healthcare system currently supports 36 da Vinci surgical robots," Hadomi added.

"We expect Korea to be a very strong market for our surgical robots and serve as a gateway to the Asia Pacific region, as it has in the past for other robotic technologies."